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Nanoparticles (NPs) are suitable systems for intracellular
delivery of vaccines or therapeutic agents, e.g., proteins or
genes. Nanosystems physicochemical properties, such as
size, shape, chemical composition and functionality,
hydrophilicity/hydrophobicity, surface chemistry and
charge,[1–8] by affecting protein adsorption, influence
mechanisms involved in nanomaterial/cell interactions,
endocytosis, intracellular trafficking, and, therefore, resul-
tant cellular responses.[7,9–11] Minor variations in NPs size
and surface charge, or the usage of different cell lines, may
alter their uptake process as exemplified by NPs made of
chitosan with high surface charge and large particle size,
which were phagocytozed more efficiently by murine
macrophages.[12] In another example, the uptake rate, the
mechanism of internalization and the concentration oflibrary.com DOI: 10.1002/mabi.201200075
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phages were shown to be correlated with the NPs
mechanical properties.[13] Therefore, full characterization
of the relationship between NPs features and their
internalization mechanisms is necessary for controlled
delivery.
The cell uptake of nanomaterials can occur by phago-
cytosis and/or pinocytosis and their intracellular fate may
vary with the cell type and/or cell phenotype and growing
conditions.[5,6,8,14] Phagocytosis is a dynamin-dependent
actin-based mechanism characteristic of specialized pro-
fessional phagocytes, such as macrophages, neutrophils,
monocytes, and dendritic cells. Particles to be phagocytozed
may bind the phagocyte surface through specific receptors,
such as Fc, complement, mannose, and scavenger receptors.
The resultant phagosome and its contents undergo
maturation through a series of fusion and fission events,
which lead to the transfer of the cargo to late phagosomes
and ultimately lysosomes, forming a phagolysosome.[8,11]
In contrast, pinocytosis exists in almost all cell types,
though each cell will have a distinct profile of endocytic
routes, such as macropinocytosis, clathrin-mediated endo-
cytosis, caveolae-mediated endocytosis, or clathrin/caveo-
lae independent endocytosis. In these endocytic routes,
vesicles differ in their coat composition and size as well as in
the fate of the internalized material.[15] In clathrin-
mediated endocytosis ligand-bound receptors are inter-
nalized into clathrin-coated vesicles and their final scission
from the plasma membrane involves the GTPase dynamin.
Once invaginated, the clathrin coat is shed and the vesicle
then fuses with an early or sorting endosome. The cell
cytoskeleton in many cases then defines spatial regulation
and movement of the endocytic vesicle toward the interior
of the cells. Receptor/ligand complexes dissociate at the
low pH generated by vacuolar proton ATPases. The fate of
the ligand and receptor is then variable: either transferred
to trans-Golgi network, trafficked together to late endo-
somes and lysosomes for degradation, or recycled in early
and recycling endosomes.[8,16,17] Caveolae consist of plasma
membrane microdomains enriched in caveolins, cavins,
cholesterol, and sphingolipids.[18,19] The uptake of caveolae-
mediated endocytosis occurs at a much slower rate than
that of clathrin-mediated endocytosis.[20,21] There is
evidence that caveolae vesicles can translocate to the
endoplasmic reticulum or to the Golgi complex,[18,22] enter
the endosomal pathway,[19] or in some cases, bypass
lysosomes.[8] Caveolae-mediated endocytosis is the most
prominent transendothelial pathway.[8]
NPs may be internalized by multiple or single pathways.
The cellular uptake profile of hydrophobically modified
glycol chitosan NPs in human epithelial carcinoma (HeLa)
cells is time- and dose-dependent, involving several distinct
uptake pathways, such as macropinocytosis, clathrin-, and
caveolae-mediated endocytosis.[23] On the other hand, thewww.MaterialsViews.com
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human arterial smooth muscle cells (HASMCs) is an
energy-dependent process involving clathrin- but not
caveolae-mediated endocytosis.[24] In another example,
human lung adenocarcinoma (A549) cells internalize
PLGA nanospheres, modified or not with chitosan,
by saturable, time-, temperature-, and concentration-
dependent clathrin-mediated endocytosis.[25]
We recently showed that the amphiphilic mannan
synthesized by the Michael addition of hydrophobic 1-
hexadecanethiol to vinyl methacrylated mannan, origi-
nates in aqueous medium the formation of a self-assembled
nanogel, through hydrophobic interactions among alkyl
chains.[26] Mannan nanogel has long-term stability, sphe-
rical shape, polydisperse size distribution, near neutral
surface charge and mean hydrodynamic diameter between
50 and 140 nm.[26] Proteins (e.g., bovine serum albumin)
and hydrophobic drugs (e.g., curcumin) are spontaneously
incorporated in the mannan nanogel, being stabilized by
the hydrophobic domains randomly distributed within the
nanogel,[26] opening the possibility for the development of
applications as potential delivery systems for therapeutic
molecules. Mannan nanogel is being developed in our
laboratory as a vaccination platform. Therefore, in this
work, the phagocytic cell internalization kinetics and
uptake mechanism(s) of fluorescein-labeled mannan nano-
gel were evaluated by flow-cytometric (FACS) analysis and
confocal laser scanning microscopy (CLSM) using several
endocytic inhibitors. Intracellular trafficking pathway(s)
were also studied by CLSM.2. Experimental Section
2.1. Materials
Mannan-VMA-SC16 (VMA: vinyl methacrylate, SC16: hydrophobic
alkyl chain) was synthesized as previously described[26] with 31
acrylate groups (DSVMA 31%) and 20 alkyl chains (DSC16 20%) per 100
mannose residues. Resultant amphiphilic mannan was named
MVC16-31-20. Organic and inorganic reagents of laboratory grade
were purchased from Sigma (St. Louis, MO, USA) and used without
any further purification. All cell culture products were purchased
from Sigma, unless otherwise specified.2.2. Preparation of Self-Assembled SAMSA
Fluorescein-Labeled Mannan Nanogel
Mannan nanogel covalently labeled with 5-{[2-(and-3)-S-(acetyl-
mercapto)succinoyl]amino}fluorescein (SAMSA fluorescein; Mole-
cular Probes, Invitrogen, Carlsbad, CA, USA) resulted from the
reaction between the thiol group of SAMSA fluorescein with the
grafted methacrylate not substituted with SC16 of MVC16-31-20, as
previously described.[26] To remove any residual nonconjugated
fluorescein, obtained sterile stock colloidal dispersion of labeled
MVC16-31-20 (2 mg mL1) was repeatedly washed by ultrafiltra-12, 1172–1180
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cut-off, 5103; Millipore, Billerica, MA, USA) with sterile pyrogen-
free phosphate-buffered saline (PBS) until no fluorescence was
detected in the filtrate. The degree of labeling was determined from
the absorbance of the labeled nanogel at 495 nm recorded in V560
spectrophotometer (JASCO, UK) and the nanogel formation was
confirmed by dynamic light scattering (DLS; Malvern Zetasizer
NANO ZS, Malvern Instruments Limited, UK), as was previously
described.[26] Fluorescence emission spectra were recorded in a
Spex Fluorolog 3 spectrofluorimeter (Horiba Jobin Yvon IBH Ltd).2.3. Cell Culture
Female BALB/c mice (6–8 weeks old) were purchased from
Charles River (Barcelona, Spain). Animals were kept at the animal
facilities of the Institute Abel Salazar during the experiments.
Hiding and nesting materials were provided as enrichment.
Procedures involving mice were performed according to the
European Convention for the Protection of Vertebrate Animals
used for Experimental and Other Scientific Purposes (ETS 123)
and 86/609/EEC Directive and Portuguese rules (DL 129/92).
In order to obtain bone-marrow-derived macrophages (BMDM),
femurs and tibias were collected under aseptic conditions and
flushed with Hanks’ balanced salt solution. The resulting cell
suspension was centrifuged at 500g and resuspended in RPMI
1640 medium supplemented with 4-(2-hydroxyethyl)-1-piper-
azineethanesulfonic acid (HEPES; 0.010 M), 10% heat-inactivated
fetal bovine serum (FBS), penicillin (60 IU mL1), streptomycin
(60mg mL1), b-mercaptoethanol (5104 M) (complete RPMI
[cRPMI]), and 10% L929 cell-conditioned medium (LCCM). To
remove fibroblasts or differentiated macrophages, cells were
incubated on Petri dishes (Sarstedt, Canada), overnight at 37 8C
in a 5% CO2 atmosphere. Then nonadherent cells were collected
with warm cRPMI, centrifuged at 500g, resuspended in cRPMI at
a density of 5 105 cells mL1 and distributed 1 106 cells per
fluorodish (WPI, UK) or 5105 cells per well in 24-well plates
(Sarstedt). Cells were incubated at 37 8C in a 95% humidified
atmosphere containing 5% CO2. Four days after seeding, 10% of
LCCM was added, and the medium was renewed on the seventh
day. After 10 days in culture, cells were completely differentiated
into macrophages. This method allows for the differentiation of
a homogeneous primary culture of macrophages that retain the
morphological, physiological, and surface markers characteristics
of these phagocytic cells.[27–29]2.4. Kinetics of Mannan Nanogel Internalization by
BMDM
The BMDM seeded in 24-well plates (Sarstedt) were incubated at
37 8C in a 95% humidified atmosphere containing 5% CO2 for 0, 0.5,
1, 2, 6, and 16 h, with SAMSA fluorescein-labeled nanogel in cRPMI
(0.01, 0.05, and 0.1 mg mL1) or only with cRPMI (negative control).
Then cells were washed twice with PBS and detached mechanically
in 400mL of PBS with 10 mM of sodium azide and 1% of bovine
serum albumin (FACS buffer). The cell suspension of each well was
divided in two aliquots and transferred into polystyrene tubes for
FACS analysis in a FACScan flow cytometer (Becton Dickinson, SanMacromol. Biosci. 201
 2012 WILEY-VCH Verlag GmbJose, CA, USA) using the CellQuest software (Becton Dickinson)
before and after adding 1mL of propidium iodide (PI; 500 ng mL1)
or 40mL of trypan blue (2.5 mg mL1) to different aliquots. Data
were collected for 20000 live cells per sample. Before FACS analysis
samples were kept at 4 8C and protected from light. Dead cells were
excluded from the analysis by PI incorporation.2.5. Mechanism of Mannan Nanogel Uptake by
BMDM
2.5.1. Inhibitors
The uptake mechanisms and intracellular fate of the labeled
mannan nanogel in BMDM were studied by using inhibitors at
the following concentrations and pre-incubation periods: sodium
azide (NaN3; 0.1% w/v) and 6-deoxyglucose (0.05 M) for 30 min;
[7,24]
cytochalasin D (2105 M) for 1 h;[6,30] mannan (200mg mL1) for
30 min;[31] monodansylcadaverine (3104 M) for 1 h;[32] sucrose
(0.450 M) for 1 h;[24,25] filipin (1mg mL1) for 30 min;[7,24,25]
brefeldin A (5106 M) for 1 h;[24] and nocodazole (3.3105 M)
for 1 h.[6,9] Control cells were incubated in the corresponding
volume of drug diluent.
2.5.2. FACS Analysis
To study the effect of the different inhibitors on the nanogel uptake,
BMDM seeded in 24-well plates were pre-incubated with each
inhibitor in cRPMI in conditions described above, at 37 8C in a
95% humidified atmosphere containing 5% CO2. Cells were co-
incubated with each inhibitor, at the same concentration used for
pre-incubation, together with SAMSA fluorescein-labeled nanogel
(0.1 mg mL1) in cRPMI, for 1 h at 37 8C. BMDM were incubated
with cRPMI (negative control), with labeled nanogel in cRPMI
(positive control), or with the inhibitor in cRPMI. Then cells were
washed twice with PBS and mechanically detached in 600mL PBS.
The cell suspension of each well was divided in two aliquots that
were transferred into polystyrene tubes for FACS analysis. Cells
of one aliquot were washed in FACS buffer and immediately
analyzed. Cell autofluorescence was determined according to the
negative control. Dead cells were excluded by PI incorporation.
A cell viability of 85% was arbitrarily chosen as the minimum
allowable to perform the uptake assays. Data were collected
from 20000 cells per sample. Cells of the other aliquot were fixed
with 2% formaldehyde for 25 min at room temperature and
protected from light. Then cells were sequentially washed with
PBS and FACS buffer and analyzed. Cell autofluorescence was
determined by using the negative control. Data were collected from
50000 cells per sample. The fluorescence of cells incubated with the
inhibitors was compared to that of the positive control and
the extent of inhibition was calculated as follows: inhibitory
effect (%)¼100–mean fluorescence intensity (MFI) inhibitor
sample/MFI of positive control 100.
2.5.3. Confocal Studies
For CLSM, BMDM plated in 24-well plates were mechanically
detached in cRPMI and seeded (5105 cells per well) on coverslips
(Sarstedt). To study the effect of different inhibitors on the
intracellular distribution of the labeled nanogel, cells were first2, 12, 1172–1180
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Red1 transferrin (100mg mL1; Molecular Probes, Invitrogen)
or LysoTracker1 Red DND-99 (2.5106 M; Molecular Probes,
Invitrogen) with lem¼612 nm in cRPMI for 1 h. Texas Red
transferrin labels early and recycling endosomes and LysoTracker,
a live-cell acid sensitive probe, colorless at physiological pH, labels
late endosomes and lysosomes. Early endocytic vesicles have
physiological pH, early endosomes pH 5.9–6 and late endosomes
and lysosomes pH 4.5–5.5.[33] The labeled nanogel was added
(0.1 mg mL1) and cells were incubated for another hour at 37 8C in
a 95% humidified atmosphere containing 5% CO2. At that point,
cells were washed twice with PBS, fixed with 2% formaldehyde for
25 min at room temperature, permeabilized with 0.1% Triton-100
in PBS for 5 min and incubated overnight at 4 8C with 1:100 Alexa
Fluor1 488-labeled anti-fluorescein/Oregon Green rabbit poly-
clonal IgG antibody (Molecular Probes, Invitrogen; lem¼520 nm).
This labeled anti-fluorescein antibody was used to amplify the
detectable signal of the SAMSA fluorescein-labeled nanogel above
the detector noise level. Cell nuclei were finally labeled with 4’-6-
diamidino-2-phenylindole (DAPI; 120 ng mL1; lem¼ 461 nm) for
5 min at room temperature. Each of the last four steps was followed
by three washes with PBS. Results were compared with a
positive control prepared as described before but without using
any inhibitor. Control samples were prepared by using the same
experimental conditions with each fluorophore separately for
excitation cross-talk and emission bleed-through analysis, or in the
absence of staining to determine autofluorescence. Samples were
observed with a confocal laser scanning microscope (Olympus
BX61/FluoViewTM FV1000). Five Z-series with 0.75mm Z-spacing
were obtained for each treatment by using the following
microscope settings: three lasers (405, 488, and 559 nm) in the
three narrow bandwidth emission filter, sequential acquisition and
Kalman filter mode, 60 oil objective with numerical aperture of
1.42, 2 optical zoom, and 800 800 pixel size with four detectors.
Detector gains were set to be constant between samples to
facilitate sample comparison.
2.5.4. Confocal Image Analysis
The experimental design, image acquisition (as detailed above),
qualitative and quantitative evaluation were performed following
guidelines previously described for colocalization purposes.[34–40]
Fluorescence intensity measurements, qualitative evaluation of
overlapping pixels by dye-overlay and threshold-overlap, and
quantitative threshold-based analysis – annotation and statistics –
were obtained with Olympus FluoView1000 (FV viewer v.2.0)
software after removing unspecific events generated by noise and
background. The annotation analysis provides the number of
total (T), green (G), red (R), and colocalized (C) pixels and
colocalization coefficients, such as colocalization coefficient in
green (CG, corresponding to the ratio between C and G),
colocalization coefficient in red (CR, corresponding to the ratio
between C and R), colocalization coefficient in total pixels (CT,
corresponding to the ratio between C and T). The statistical analysis
of the software provides the Pearson’s correlation coefficient
rp,[41,42] the overlap coefficient r,[42] and colocalization coefficients
M1 (orMgreen) andM2 (orMred).
[36,42] To calculate the relative extent
of spatial overlap of SAMSA fluorescein-labeled nanogel and Texas
Red transferrin or LysoTracker labeling, the correlation, overlap andwww.MaterialsViews.com
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single colocalization coefficient that fully describes a particular
situation. Colocalization measurements were obtained using a
two-dimensional scatterplot of intensity ranges of red channel
versus green channel where thresholds were defined using the
results obtained with controls. The colocalization with SAMSA
fluorescein-labeled nanogel was evaluated in ‘‘regions of interest’’
(ROIs) corresponding to early and recycling endosomes (labeled
with Texas Red transferrin) or late endosomes and lysosomes
(labeled with LysoTracker) with area greater than 12 pixels2
randomly selected in 10 cells per experimental condition. The
fluorescence intensity measurements were performed in two color
three-dimensional microscopic images using ROIs corresponding
to cytoplasm of 20 cells per experimental condition. The reported
values represent the mean standard deviation (S.D.) of inhibitory
effect (%)¼100–MFI for the inhibitor sample/MFI of positive
control 100.2.6. Statistical Analysis
Statistical significance of the mean values of inhibitory effects (%)
caused by different inhibitors, as evaluated by FACS analysis and
confocal image analysis, was determined by Student’s two-tailed
unpaired t-test (at the 95% confidence interval) using GraphPad
Prism version 4.00 for Windows (GraphPad Software, San Diego, CA,
USA). Statistical significant differences were labeled with a single
asterisk (p< 0.05), two asterisks (p< 0.01), and three asterisks
(p< 0.001).3. Results and Discussion
3.1. Physical Properties of SAMSA Fluorescein-Labeled
Mannan Nanogel
We initially determined if labeling with the SAMSA
fluorescein had any effects on the physical properties
of the nanogel. According to dynamic light scattering
(DLS) measurements, the colloidal dispersion of labeled
nanogel in PBS (2 mg mL1) showed a z-average equal
to 168.0 3.2 nm, with polydispersity index (PdI) of
0.270 0.008, and a zeta potential of 11.8 1.4 mV.
These characteristics were similar to those observed for
colloidal dispersion of non-labeled nanogel in PBS
(2 mg mL1): z-average equal to 154.1 5.6 nm, with PdI
of 0.229 0.007, and zeta potential of 10.9 1.4 mV.
The colloidal dispersion of labeled nanogel in cRPMI
(0.1 mg mL1) showed z-average equal to 163.8 2.8 nm,
with PdI of 0.576 0.084, and zeta potential of
11.5 2.1 mV. Furthermore, the labeled nanogel was
not affected by the presence of inhibitors as confirmed by
DLS, see Figure S1 in Supporting Information.
The UV-Vis spectrum of the labeled nanogel presented a
sharp single peak, with maximum absorbance at 495 nm of
0.9 0.05 (2 mg mL1 in PBS), characteristic of covalently
linked fluorescein (according to the manufacturer). As12, 1172–1180
& Co. KGaA, Weinheim 1175
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S. A. Ferreira, A. Correia, P. Madureira, M. Vilanova, F. M. Gamapreviously reported,[26] size, zeta potential and UV-Vis
spectrum of the colloidal dispersion in PBS were stable, if
stored at 4 8C and protected from light. SAMSA fluorescein-
labeled nanogel fluorescence emission spectrum in cRPMI
was not affected by any of the inhibitors at the concentra-
tion used in uptake inhibition analysis, see Figure S2 in
Supporting Information.3.2. Kinetics of Mannan Nanogel Internalization by
BMDM
In order to discriminate between internalized and surface-
adherent SAMSA fluorescein-labeled mannan nanogel,
samples were analyzed by FACS before and after the
addition of trypan blue. Trypan blue is a vital dye, incapable
of penetrating intact cell membranes, which is known
to quench extracellular and surface-bound fluorescein
fluorescence.[7,14,43] The MFI of BMDM incubated with
labeled nanogel was not significantly different before and
upon trypan blue addition (Table S1 in Supporting
Information), indicating that the detected fluorescence
was due to nanogel internalized by macrophages.
Mannan nanogel uptake by BMDM was found to be time-
and concentration-dependent (Figure 1). After an initial
linear stage of approximately 4 h, a trend toward saturation
occurred, as typically observed in the endocytosis of many
probes.[7,13,24,25,44]3.4. Uptake Mechanisms and Intracellular Fate of the
Mannan Nanogel in BMDM
Eight inhibitory conditions were selected to examine
the pathways of cellular uptake and intracellular
trafficking of the mannan nanogel by using FACS and
CLSM analysis.Figure 1. FACS analysis of murine BMDM internalization of SAMSA
fluorescein-labeled mannan nanogel at three different concen-
trations. Each point represents the MFI S.D. of duplicate
samples of one experiment, representative of two independent
experiments.
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mixture of NaN3 and 6-deoxyglucose,
[7] the 54 5% uptake
reduction detected by FACS analysis (Figure 2) suggests
active internalization. NaN3 prevents the production of ATP
by interfering with the glycolytic and oxidative metabolic
pathways.[13] In the inhibitory conditions used in the
assay, the mannan nanogel internalization was not fully
blocked, as it has been also reported by others.[13,45,46] A
possible explanation for this partial blockade could lie on
the presence of exogenous ATP and glucose in the culture
medium.[12,47] The inhibitory effect of energy depletion
conditions was confirmed by using CLSM, as a reduction of
nanogel internalization was also observed (Figure 3 and 4).
A lower inhibitory effect was nevertheless detected in the
presence of Texas Red transferrin (Figure 3).
Cytochalasin D, a drug that disrupts F-actin filaments via
actin depolymerization,[6] inhibited nanogel uptake by
43 13%, as assessed by FACS analysis (Figure 2). F-actin
has been shown to be involved in phagocytosis, macro-
pinocytosis, and clathrin- and caveolae-mediated endo-
cytosis.[48] A similar inhibitory effect of cytochalasin D was
confirmed by CLSM analysis (Figure 3 and 4).
The mannose receptor (MR) is a cell surface receptor
primarily expressed on antigen-presenting cells (APC),
namely, macrophages and dendritic cells. MR-mediated
phagocytosis[49] is an important pathway for antigen
presentation in the context of major histocompatibility
complex (MHC) class II molecules[50,51] and class I
molecules,[52,53] playing a key role in host defense and
providing a link between innate and adaptive immu-
nity.[54] As MR is a key molecule in antigen recognition, this
receptor is a privileged target for vaccine and drug delivery
to macrophages.[52,55] Mannan nanogel endocytosis was
significantly inhibited by competition with soluble
mannan (inhibitory effect: 52 1%, Figure 2). A similarFigure 2. Uptake mechanism inhibition analysis of mannan nano-
gel by murine BMDM. Results represent the mean of % inhibitory
effect S.D. obtained by FACS analysis in a representative
experiment performed in triplicate (p<0.05, p<0.01, and
p<0.001).
2, 12, 1172–1180
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Figure 4. Confocal microscopy uptake and intracellular trafficking
inhibition analysis of mannan nanogel by murine BMDM. (a)
Confocal images of a representative cell at a certain Z-stack (scale
bar¼ 5mm). Blue indicates DAPI-stained nuclei. (b) Fluorescence
intensity measurements of LysoTracker and SAMSA fluorescein-
labeled nanogel present in the cytoplasm (mean of % inhibitory
effect S.D.; n¼ 20; p<0.05, p<0.01, and p<0.001)
obtained by image analysis. Results are from one experiment
representative of two independent experiments.
Figure 3. Confocal microscopy uptake and intracellular trafficking
inhibition analysis of mannan nanogel in murine BMDM. (a)
Confocal images of a representative cell at a certain Z-stack (scale
bar¼ 5mm). Blue indicates DAPI-stained nuclei. (b) Fluorescence
intensity measurements of Texas Red transferrin and SAMSA
fluorescein-labeled nanogel present in the cytoplasm (mean of
% inhibitory effect S. D.; n¼ 20; p<0.05, p<0.01, and
p<0.001) obtained by image analysis. Results are from one
experiment representative of two independent experiments.
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CLSM analysis (Figure 3 and 4). These results indicate that
nanogel made of mannan targets the MR and that this
receptor is involved in uptake of the nanogel.
The effect of clathrin-mediated endocytosis inhibition
on nanogel uptake was tested by using monodansylcada-
verine, which blocks the formation of clathrin-coated
pits.[56] Inhibition of energy-dependent clathrin-mediated
endocytosis was further tested via sucrose-induced hyper-
tonicity, which prevents the assembly of clathrin-coated
pits.[24,25,57] The uptake of the mannan nanogel in
monodansylcadaverine-treated and sucrose-treated cells
was markedly reduced; with an inhibitory effect of 75 2
and 85 2%, respectively, as determined by FACS analysis
(Figure 2). A marked inhibition, however to a lesser extent,www.MaterialsViews.com
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Transferrin is generally recognized as a ligand exclusively
internalized via the clathrin-coated-pit pathway;[9]
monodansylcadaverine and sucrose treatments similarly
reduced, as expected, the uptake of the Texas Red-
conjugated probe by 70–80% (Figure 3). Altogether, these
results indicate that clathrin-mediated endocytosis also
contributes to the internalization of mannan nanogel.
To examine clathrin-independent endocytosis, which
includes caveolae-mediated endocytosis, cells were incu-
bated with filipin, a cholesterol-binding drug that perturbs
cholesterol function.[24,58,59] Filipin did not reduce the
uptake of nanogel, as judged from FACS analysis (inhibitory
effect: 8 3%, Figure 2). A slight inhibitory effect was
however detected by CLSM analysis (Figure 3 and 4).12, 1172–1180
& Co. KGaA, Weinheim 1177
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S. A. Ferreira, A. Correia, P. Madureira, M. Vilanova, F. M. GamaAlthough we cannot exclude that uptake could also occur by
caveolae-mediated endocytosis, this pathway would be a
minor route for this nanogel.
Brefeldin A interferes with intracellular vesicular trans-
port inducing tubulation of Golgi complex, endosomes, and
lysosomes.[60] Brefeldin A reduced the mannan nanogel
uptake and intracellular trafficking in murine BMDM. The
inhibitory effect measured by FACS analysis corresponded
to 43% (Figure 2), while it was less marked when evaluated
by CLSM analysis (Figure 3 and 4).
Nocodazole inhibits endosome-lysosome trafficking by
interfering with the microtubule network causing depoly-
merization of microtubules.[6,61,62] Nocadozole reduced the
uptake of nanogel by 31 3%, as measured by FACS
analysis (Figure 2). A similar effect was observed by using
CLSM (Figure 3 and 4) indicating that a dynamic micro-
tubule network, which is important for vesicular transport,
is necessary for mannan nanogel uptake.
The visual-based evaluation of colocalization is prone to
error and bias, as the ‘‘amount of yellow’’ resulting from the
superposition of two fluorescence images, colored ‘‘green’’
and ‘‘red,’’ depends on the brightness of the merged images,
the monitor settings, as well as the viewer’s perception.Table 1. Colocalization coefficients calculated by confocal image analy
mannan nanogel (green), within early and recycling endosomes, l
lysosomes, labeled with LysoTracker Red (mean S.D., n¼ 10).
Sample CGa) C
Early and recycling endosomes
positive control 0.83 0.10 0.47
sodium azideþ 6-deoxyglucose 0.63 0.18 0.77
filipin 0.55 0.13 0.83
brefeldin A 0.54 0.17 0.54
nocodazole 0.82 0.10 0.68
Late endosomes and lysosomes
positive control 0.84 0.13 0.65
sodium azideþ 6-deoxyglucose 0.80 0.02 0.69
mannan 0.86 0.14 0.49
sucrose 0.63 0.12 0.38
filipin 0.88 0.11 0.51
brefeldin A 0.65 0.16 0.82
nocodazole 0.95 0.03 0.75
a)Colocalization coefficient in green pixels, corresponding to the ratio
confocal image analysis (annotation); b)Colocalization coefficient in
colocalized and red pixels, obtained by confocal image analysis (annot
the ratio between the number of colocalized and total pixels, obtained b
M1 or Mgreen, calculated as previously described,
[42] obtained by conf
Mred, calculated as previously described,
[42] obtained by confocal ima
Macromol. Biosci. 201
 2012 WILEY-VCH Verlag GmbTherefore the fluorescence intensity was quantified by
image analysis in ROIs corresponding to the cytoplasm,
where the acquired intensity better reflects the concentra-
tion of fluoroprobes (Figure 3 and 4). Moreover, the
colocalization was quantified by image analysis in ROIs
corresponding to endosomes or lysosomes with area
superior to 12 pixels2 randomly selected in 10 cells per
experimental condition. This design is very important
because the inclusion of irrelevant pixels not corresponding
to the cellular structures under study may lead to
significant mistakes in the colocalization coefficients
calculated.[40]
The inhibitory effect was evaluated by confocal image
analysis in terms of fluorescence intensity of Texas Red
transferrin and LysoTracker labeling. The fluorescence
intensity of Texas Red transferrin was drastically reduced
in the presence of cytochalasin D, mannan, monodansyl-
cadaverine, and sucrose. Consequently, early and recycling
endosomes were impossible to isolate for colocalization
evaluation (Figure 3). For the other used inhibitors and
positive control, the degree of colocalization is shown in
Table 1. The colocalization coefficients CG,CR, CT,M1, andM2
were the most suitable choices in this study, because thesis, after murine BMDM internalization of SAMSA fluorescein-labeled
abeled with Texas Red transferrin, or within late endosomes and
R
b) CTc) M1 or
Mgreend)
M2 or
Mrede)
 0.14 0.40 0.10 0.79 0.10 0.46 0.20
 0.10 0.47 0.01 0.53 0.28 0.46 0.34
 0.21 0.56 0.21 0.51 0.17 0.58 0.24
 0.04 0.30 0.09 0.68 0.23 0.60 0.22
 0.14 0.54 0.15 0.74 0.16 0.68 0.14
 0.30 0.50 0.25 0.78 0.12 0.58 0.29
 0.22 0.47 0.16 0.74 0.20 0.63 0.24
 0.18 0.44 0.21 0.75 0.21 0.41 0.22
 0.19 0.11 0.05 0.10 0.12 0.04 0.08
 0.26 0.51 0.20 0.77 0.20 0.38 0.20
 0.12 0.47 0.19 0.70 0.08 0.77 0.13
 0.16 0.75 0.13 0.86 0.22 0.66 0.27
between the number of colocalized and green pixels, obtained by
red pixels, corresponding to the ratio between the number of
ation); c)Colocalization coefficient in total pixels, corresponding to
y confocal image analysis (annotation); d)Colocalization coefficient
ocal image analysis (statistics); e)Colocalization coefficient M2 or
ge analysis (statistics).
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was different. When the number of pixels carrying an
intensity above the threshold t is very different, overlap
coefficient r does not provide useful information, and
colocalization coefficients M1 and M2 are the proper choice
because they are not dependent on the intensity of the
signals.[42] Also, rpvalues obtained were close to zero, which
might not necessarily mean random localization and
are difficult to interpret. LysoTracker fluorescence was
drastically reduced in the presence of cytochalasin D.
Although the fluorescence observed in monodansylcada-
verine-treated cells was not affected that much, late
endosomes and lysosomes were impossible to isolate for
colocalization evaluation in both inhibitory conditions. The
colocalization coefficients CG, CR, CT, M1, and M2 indicated
colocalization between green and red dyes in the positive
control and in cells treated with each of the tested
inhibitors, with the exception of sucrose (Table 1).
Colocalization assays with endosomal and lysosomal
markers (red fluorescence) allowed the identification of the
intracellular pathways followed by the labeled nanogel
(green fluorescence) after internalization. Nanogel was
found in the early and recycling endosomes, in the late
endosomes and lysosomes, and in the cytosol but was not
observed in the nucleus. We hypothesize that nanogel in
early endosomes, may be either recycled to the surface or
transported to the late endosomes, from which it may
escape into the cytosol or end up in lysosomes. As scattered
green fluorescence could be observed in cytosol; this might
indicate endolysosomal escape. The high degree of coloca-
lization of the labeled nanogel with the fluorescent
endosome and lysosome markers, Texas Red transferrin
and LysoTracker, confirms the expected transport of these
particles in vesicles of the endolysosomal pathway.
Our study was performed using cell culture medium
supplemented with heat-inactivated FBS. In this medium,
the protein adsorption pattern on the nanogel might be
different than the one encountered in a more physiological
situation where, for example, the complement system
could be activated and promote foreign particle recognition
by phagocytic cells.
Taken together, the results obtained in the inhibition
study reported here, suggest that the internalization of the
used mannan nanogel is mediated by multiple cellular
uptake mechanisms. This has significant implications for
drug and vaccine delivery, as intracellular trafficking is
largely dependent on initial pathway of cell entry. It might
be expected that part of nanogel uptaken by macrophages
will be trafficked to the lysosomes by MR-mediated
phagocytosis and clathrin-mediated endocytosis while
part of the nanogel may end up in the cell cytosol. As
one of the envisaged applications of this nanomaterial
concerns its usage as antigen-delivery system, the cytosolic
and endolysosomal location, might allow delivered anti-www.MaterialsViews.com
Macromol. Biosci. 2012,
 2012 WILEY-VCH Verlag GmbHgens to be presented on both MHC class I and class II
molecules.4. Conclusion
Cellular uptake profile of mannan nanogel is saturable
and time-, concentration- and energy-dependent. In vitro
experiments with endocytic inhibitors suggest that distinct
uptake pathways, such as MR-mediated phagocytosis and
clathrin-mediated endocytosis are involved in its inter-
nalization. Mannan nanogel was also visualized in the
cytosol. This observation suggests that a fraction of the
uptaken material escaped from the endolysosomal com-
partments. We have previously reported that this mannan
nanogel has tunable physicochemical properties and low
toxicity. Altogether, these findings make mannan nanogel a
promising macromolecular carrier to be used as a vaccina-
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